Homologous Chromosomes Make Contact at the Sites of Double-Strand Breaks in Genes in Somatic G0/G1-Phase Human Cells

Total Page:16

File Type:pdf, Size:1020Kb

Homologous Chromosomes Make Contact at the Sites of Double-Strand Breaks in Genes in Somatic G0/G1-Phase Human Cells Homologous chromosomes make contact at the sites of double-strand breaks in genes in somatic G0/G1-phase human cells Manoj Gandhia,1, Viktoria N. Evdokimovaa,1, Karen T.Cuencob,c, Marina N. Nikiforovaa, Lindsey M. Kellya, James R. Stringerd, Christopher J. Bakkenistd,e, and Yuri E. Nikiforova,2 aDepartment of Pathology and Laboratory Medicine, University of Pittsburgh, Pittsburgh, PA 15213; bDepartment of Oral Biology, School of Dental Medicine and cDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15219; dDepartment of Molecular Genetics, University of Cincinnati, Cincinnati, OH 45267; and eDepartments of Radiation Oncology and Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15213 Edited by James E. Cleaver, University of California, San Francisco, CA, and approved May 1, 2012 (received for review April 5, 2012) Double-strand DNA breaks (DSBs) are continuously induced in cells Results by endogenously generated free radicals and exogenous geno- Homologous Chromosomes Form Arm-Specific Contact Spontaneously toxic agents such as ionizing radiation. DSBs activate the kinase and After Exposure to Ionizing Radiation. We used four-color 3D- activity in sensor proteins such as ATM and DNA-PK, initiating FISH and confocal microscopy (11, 12) to analyze the pattern a complex DNA damage response that coordinates various DNA and frequency of interaction between homologous chromosomes repair pathways to restore genomic integrity. In this study, we in untreated and irradiated primary cultured human epithelial report the unexpected finding that homologous chromosomes thyroid cells and fibroblasts. Cells were highly enriched in G0/G1 contact each other at the sites of DSBs induced by either radiation by plating at high density in the absence of serum and other or the endonuclease I-PpoI in human somatic cells. Contact involves growth factors (84% of thyroid cells and 91% of fibroblasts were short segments of homologous chromosomes and is centered on in G0/G1 phase by FACS). For each chromosome, arm-specific a DSB in active genes but does not occur at I-PpoI sites in intergenic paints were used to visualize the p and q arm separately, and DNA. I-PpoI-induced contact between homologous genes is abro- a centromeric probe was used to monitor the location and du- gated by the transcriptional inhibitors actinomycin D and α-amanitin A fi plication of centromeres (Fig. 1 ). Contact between homologous and requires the kinase activity of ATM but not DNA-PK. Our nd- chromosomes was detected by using intensity-based image seg- ings provide documentation of a common transcription-related and mentation analysis (Fig. S1). S/G2-phase cells, which were ATM kinase-dependent mechanism that induces contact between identified by the presence of centromere duplication that occurs allelic regions of homologous chromosomes at sites of DSBs in in S phase (13), were excluded from further analysis. The accuracy human somatic cells. of the exclusion criterion was confirmed by combining PCNA (marker of S phase) or cyclin A (marker of S and G phase) (14) homologous chromosome interaction | homologous recombination 2 immunostaining and FISH analysis in selected experiments (Fig. 1 E and F). ouble-strand DNA breaks (DSBs) are continuously induced Arm-specific contact between homologous chromosomes was Din eukaryotic cells by the free radicals generated by endog- readily identified for all six chromosomes studied in epithelial enous metabolic processes and by exposure to environmental cells and all three chromosomes studied in fibroblasts. The genotoxic agents such as ionizing radiation (IR) and are con- common patterns of contact were between two homologous q – sidered to be the most dangerous DNA lesions (1 3). DSBs in- arms (Fig. 1B), between two homologous p arms (Fig. 1C), and duce a complex DNA damage response that activates DNA repair simultaneous contact between two p arms and two q arms of pathways and cell cycle checkpoints and induces chromatin homologous chromosomes, i.e., p:p and q:q contact (Fig. 1D and remodeling and apoptosis. ATM and DNA-PK, two phosphati- Fig. S2). dylinositol 3-kinase–like kinases, are primary mediators of the Analysis performed on primary thyroid epithelial cells from two DNA damage response to DSBs. Although ATM phosphorylates donors revealed that 15–26% (mean, 19%) of homologous chro- hundreds of substrates that are believed to regulate multiple mosomes had arm-specific contact in untreated cells (Fig. 1G). DNA repair pathways including DSB repair by homologous Fifteen minutes after exposure to 5-Gy IR, the frequency of arm- recombination (HR) (4, 5), DNA-PK primarily regulates a limited specific contact between homologous chromosomes doubled to group of effectors that mediate DSB repair by nonhomologous 28–45% (mean, 38%). Similar findings were observed in un- end-joining (NHEJ) (3, 6). Misrepair of DSBs can result in the treated and irradiated human fibroblasts (Fig. 1H). The frequency intrachromosomal and interchromosomal rearrangements that of contact between homologous chromosomes was ∼20-fold generate oncogenic gene fusions. Previously, we (7, 8) and others lower than the predicted frequency of DSBs induced by 5 Gy of IR (9, 10) have shown that cancer-specific chromosomal rear- (150–200 DSBs per cell; 6–8 DSBs per average-size chromo- rangements commonly arise as a result of exchange between some), indicating that if contact is due to formation of DSBs, chromosomal loci that are located in close spatial proximity at the time of DSB formation. While exploring the role of nuclear architecture and gene Author contributions: Y.E.N. and C.J.B. designed research; M.G., V.N.E., K.T., and L.M.K. topology in the generation of chromosomal rearrangements in performed research; Y.E.N., M.G., V.N.E., K.T., M.N.N., J.R.S., and C.J.B. analyzed data; and human somatic cells, we observed an unexpected finding that Y.E.N., M.G., V.N.E., M.N.N., J.R.S., and C.J.B. wrote the paper. homologous chromosomes frequently contact each other at the The authors declare no conflict of interest. sites of DSBs induced in G0/G1 cells by either IR or the re- This article is a PNAS Direct Submission. striction enzyme I-PpoI. Further characterization demonstrated 1M.G. and V.N.E. contributed equally to this work. that this contact between homologous chromosomes is initiated 2To whom correspondence should be addressed. E-mail: [email protected]. by DSBs in genes but not by DSBs in intergenic DNA, requires This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. active gene transcription, and depends on ATM kinase activity. 1073/pnas.1205759109/-/DCSupplemental. 9454–9459 | PNAS | June 12, 2012 | vol. 109 | no. 24 www.pnas.org/cgi/doi/10.1073/pnas.1205759109 Downloaded by guest on September 26, 2021 cells (range 0.6–1.6%) for all chromosomes, whether cells were irradiated or not irradiated, which likely represents a background level of random contact. Homologous Chromosomes Form Contacts at the Sites of DSBs Induced by Homing Endonuclease I-PpoI in Gene Regions but Not Outside of Genes. To determine whether contact between the corresponding arms of homologous chromosomes was induced by a DSB, and to find whether it involves the same allelic region on both homologs, we induced DSBs at specific chromosomal sites by expressing the homing endonuclease I-PpoI (15, 16) in the TPC-1 human thyroid cancer cell line (17). To introduce the I-PpoI gene, cells were transduced with the HA-ER-I-PpoI ret- rovirus (gift of M. Kastan Duke Cancer Institute, Durham, NC) by using either a single infection or three sequential infections. To induce DSBs, the infected cells were treated with 4-hydrox- ytamoxifen (4-OHT), which causes I-PpoI to enter the nucleus (16, 18). I-PpoI induction for 6 h produced multiple γH2AX foci in ∼55% and ∼75% of cells after single and triple infections, respectively (Fig. 2A). Using site-specific DNA probes, we analyzed six chromosomal regions, all diploid in TPC-1 cells (Table S1). Two of the regions have an I-PpoI site located within genes (DAB1 on 1p and GRIP1 on 12q). Two other studied regions (2qIG and 5qIG) are intergenic loci containing an I-PpoI site. Two regions that lack an I-PpoI site (16pNC and 16qNC) were also analyzed. Quantitative PCR (qPCR) analysis revealed that between 9 and 16% of the analyzed target sites were cut at 6 h after I-PpoI induction CELL BIOLOGY (Fig. 2B), as expected based on previous observations showing that in human cells I-PpoI cleaves approximately 10% of the 200–300 target sites (16, 18). FISH analysis with site-specific probes combined with cyclin A staining revealed that, in G0/G1-phase cells, I-PpoI cleavage in- duced contact between gene regions on homologous chromosomes, but did not induce contact between homologous intergenic regions or regions that do not contain an I-PpoI site (Fig. 2 C and D). For both genes (DAB1 and GRIP1), the proportion of cells showing contact at the I-PpoI site corresponded to the proportion of cells with expected cleavage at that site, estimated based on the known efficiency of cutting at each site and number of infected cells after single and triple infection. By contrast, the two intergenic regions containing an I-PpoI site exhibited no increase in allelic contact above the level observed in cells before I-PpoI entering the nucleus and in DNA regions lacking an I-PpoI site. Additionally, the frequency of contact between heterologous gene pairs, i.e., between DAB1 and GRIP1 genes, was low and unchanged when studied before (0.93 ± 0.24%) and after (0.90 ± 0.21%) DSB induction by I-PpoI. To confirm that contact between homologous genes is a gen- eral phenomenon and not restricted to specific chromosomes, we Fig.
Recommended publications
  • PDE1A Polymorphism Contributes to the Susceptibility
    Yang et al. BMC Genomics (2017) 18:982 DOI 10.1186/s12864-017-4247-8 RESEARCHARTICLE Open Access PDE1A polymorphism contributes to the susceptibility of nephrolithiasis Zhenxing Yang1†, Tao Zhou1†, Bishao Sun1, Qingqing Wang1, Xingyou Dong1, Xiaoyan Hu1, Jiangfan Zhong1,3, Bo Song2 and Longkun Li1,3* Abstract Background: Previous studies have confirmed a family risk of nephrolithiasis (NL), but only 15% of all cases are associated with an identified monogenic factor. In clinical practice, our group encountered a patient with NL combined with cystic kidney disease that had 3 affected family members. No known mutations association with NL was detected in this family, and thus further investigation of the molecular cause of NL was deemed to be necessary. Results: Quality analysis from the sequencing stage showed a more than 80-fold average depth and 95% coverage for each sample, and six mutations within six genes were chosen as candidate variants for further validation. Genotyping of rs182089527in the phosphodiesterase 1A (PDE1A) gene in the validation cohort indicated that the alternative allele was present in 15 patients with heterozygosity and in 1 patient with homozygosity, and exhibited significant enrichment in NL patients (Fisher’s exact test, adjusted p = 0.0042) and kidney cystic patients (Fisher’s exact test, adjusted p = 0.067) compared to controls. In addition, function analysis displayed a significant decrease in the protein and mRNA expression levels resulting from the rs182089527 mutant sequence compared with the wild-type sequence. Moreover, patients with this mutation displayed a high level of creatinine and urea in urinalysis. Conclusions: Our study provides genetic evidence that the rs182089527 mutation in PDE1A is involved in the development of NL and kidney cysts, which should help to improve personalized medicine for diagnosis and treatment.
    [Show full text]
  • Genes Associated with Autism Spectrum Disorder
    Brain Research Bulletin 88 (2012) 543–552 Contents lists available at SciVerse ScienceDirect Brain Research Bulletin jo urnal homepage: www.elsevier.com/locate/brainresbull Review Genes associated with autism spectrum disorder a,∗ a,c b Xiaohong Li , Hua Zou , W. Ted Brown a Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, United States b Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, New York, NY 10314, United States c Department of Obstetrics & Gynecology, Nanfang Hospital, Guangzhou, China a r t i c l e i n f o a b s t r a c t Article history: Autism spectrum disorder (ASD) is a heterogeneous grouping of neurodevelopmental disorders charac- Received 14 May 2012 terized by impairment in social interaction, verbal communication and repetitive/stereotypic behaviors. Accepted 31 May 2012 Much evidence suggests that ASD is multifactorial with a strong genetic basis, but the underlying mecha- Available online 9 June 2012 nisms are far from clear. Recent advances in genetic technologies are beginning to shed light on possible etiologies of ASD. This review discusses current evidence for several widely studied candidate ASD genes, Keywords: as well as various rare genes that supports their relationship to the etiology of ASD. The majority of the Autism spectrum disorder data are based on molecular, cytogenetic, linkage and association studies of autistic subjects, but newer Candidate genes methods, including whole-exome sequencing, are also beginning to make significant contributions to Genetic susceptibility Etiology our understanding of autism. Published by Elsevier Inc.
    [Show full text]
  • Bayesian Prognostic Model for Genomic Discovery in Bipolar Disorder
    Bayesian Prognostic Model for Genomic Discovery in Bipolar Disorder Swetha S. Bobba1,2,3, Amin Zollanvari2,3,4,6 and Gil Alterovitz2,3,4,5 1Vignana Bharathi Institute of Technology, Hyderabad, AP 501301, India 2Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115, U.S.A. 3Children’s Hospital Informatics Program at Harvard-MIT, Division of Health Science, Boston, MA 02115, U.S.A. 4Partners Healthcare Center for Personalized Genetic Medicine, Boston, MA 02115, U.S.A. 5Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, U.S.A. 6Department of Electrical and Electronics Engineering, Istanbul Kemerburgaz University, Istanbul, Turkey Keywords: Bayesian Theory, Gene Expression, Bipolar Disorder, External Cross-Validation. Abstract: Integrative approaches that incorporate multiple experiments have shown a potential application in the discovery of disease-related attributes. This study presents a unique, data-driven, integrative, Bayesian approach to merge gene expression data from various experiments into prognostic models and evaluate them for the discovery of bipolar-related attributes. Two prognostic models were constructed: a singly- structuredBayesian and a Bayesian multi-net model, which differentiated Bipolar disease state at a higher level of abstraction. These prognostic models were evaluated to find the most common attributes responsible for the disease and their AUROC, using external crossvalidation. The multi-net model achieved an AUROC of 0.907 significantly outperforming the single-structured model with an AUROC of 0.631. The study found six new genes and five chromosomal regions associated with the bipolar state. Enrichment analysis performed in this study revealed biological concepts and proteins responsible for the disease.
    [Show full text]
  • 2Q33.1 Deletions and Other Deletions Between 2Q31 and 2Q33
    2q33.1 deletions and other deletions between 2q31 and 2q33 rarechromo.org Deletions between 2q31 and 2q33 A chromosome deletion means that a part of one of the body’s chromosomes has been lost or deleted. If the missing chromosome material contains important genes, developmental delay, some learning difficulties and health problems may occur. How important these problems are depends mostly on how much of the chromosome has been lost and where the deletion is. Genes and chromosomes Our bodies are made up of billions of cells. Most of the cells contain a complete set of 20-25,000 genes. Genes act like a set of instructions, controlling our growth and development and how our bodies work. Genes are carried on microscopically small, thread-like structures called chromosomes. There are usually 46 chromosomes, 23 inherited from our mother and 23 inherited from our father, so we have two sets of 23 chromosomes in ‘pairs’. Apart from two sex chromosomes (two Xs for a girl and an X and a Y for a boy), the chromosomes are numbered 1 to 22, generally from largest to smallest. Chromosome 2 is almost the largest chromosome and contains nearly 1400 known genes. Each chromosome has a short arm (at the top in the diagram below) called p from petit, the French word for small, and a long arm called q (at the bottom). In a 2q deletion, material has been lost from the long arm of one of the two chromosome 2s. Looking at 2q31 to 2q33 You cannot see chromosomes with the naked eye, but if you stain them and enlarge their image many hundreds of times Short (p) using a high-powered microscope, you can see that each one arm has a pattern of light and dark bands.
    [Show full text]
  • BMC Bioinformatics Biomed Central
    BMC Bioinformatics BioMed Central Research article Open Access Correlated fragile site expression allows the identification of candidate fragile genes involved in immunity and associated with carcinogenesis Angela Re*1, Davide Cora1,4, Alda Maria Puliti2,3, Michele Caselle1,4 and Isabella Sbrana2 Address: 1Dipartimento di Fisica Teorica dell'Università degli Studi di Torino e INFN, Via P. Giuria 1 – I 10125 Torino, Italy, 2Dipartimento di Biologia dell'Università degli Studi di Pisa, Via San Giuseppe 22 – I 56126 Pisa, Italy, 3Laboratorio di Genetica Molecolare, Istituto G.Gaslini, L.go Gaslini 5 – I 16147 Genova, Italy and 4Centro Interdipartimentale Sistemi Complessi in Biologia e Medicina Molecolare, Via Accademia Albertina 13 – I 10123 Torino, Italy Email: Angela Re* - [email protected]; Davide Cora - [email protected]; Alda Maria Puliti - [email protected]; Michele Caselle - [email protected]; Isabella Sbrana - [email protected] * Corresponding author Published: 18 September 2006 Received: 27 March 2006 Accepted: 18 September 2006 BMC Bioinformatics 2006, 7:413 doi:10.1186/1471-2105-7-413 This article is available from: http://www.biomedcentral.com/1471-2105/7/413 © 2006 Re et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Common fragile sites (cfs) are specific regions in the human genome that are particularly prone to genomic instability under conditions of replicative stress. Several investigations support the view that common fragile sites play a role in carcinogenesis.
    [Show full text]
  • Unraveling the Molecular Mechanism Underlying ALS-Linked Astrocyte
    Unraveling the molecular mechanism underlying ALS- linked astrocyte toxicity for motor neurons Burcin Ikiz Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2013 © 2013 Burcin Ikiz All rights reserved Abstract Unraveling the molecular mechanism underlying ALS-linked astrocyte toxicity for motor neurons Burcin Ikiz Mutations in superoxide dismutase-1 (SOD1) cause a familial form of amyotrophic lateral sclerosis (ALS), a fatal paralytic disorder. Transgenic mutant SOD1 rodents capture the hallmarks of this disease, which is characterized by a progressive loss of motor neurons. Studies in chimeric and conditional transgenic mutant SOD1 mice indicate that non-neuronal cells, such as astrocytes, play an important role in motor neuron degeneration. Consistent with this non-cell autonomous scenario are the demonstrations that wild-type primary and embryonic stem cell- derived motor neurons selectively degenerate when cultured in the presence of either mutant SOD1-expressing astrocytes or medium conditioned with such mutant astrocytes. The work in this thesis rests on the use of an unbiased genomic strategy that combines RNA-Seq and “reverse gene engineering” algorithms in an attempt to decipher the molecular underpinnings of motor neuron degeneration caused by mutant astrocytes. To allow such analyses, first, mutant SOD1- induced toxicity on purified embryonic stem cell-derived motor neurons was validated and characterized. This was followed by the validation of signaling pathways identified by bioinformatics in purified embryonic stem cell-derived motor neurons, using both pharmacological and genetic techniques, leading to the discovery that nuclear factor kappa B (NF-κB) is instrumental in the demise of motor neurons exposed to mutant astrocytes in vitro.
    [Show full text]
  • G Protein-Coupled Receptors As Targets for Approved Drugs: How Many Targets and How Many Drugs? S
    Supplemental material to this article can be found at: http://molpharm.aspetjournals.org/content/suppl/2018/01/03/mol.117.111062.DC1 1521-0111/93/4/251–258$35.00 https://doi.org/10.1124/mol.117.111062 MOLECULAR PHARMACOLOGY Mol Pharmacol 93:251–258, April 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW—AXELROD SYMPOSIUM 2017 G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? s Krishna Sriram and Paul A. Insel Departments of Pharmacology (K.S., P.A.I.) and Medicine (P.A.I.), University of California San Diego, La Jolla, California Downloaded from Received November 8, 2017; accepted December 21, 2017 ABSTRACT Estimates vary regarding the number of G protein-coupled drugs target GPCRs. GPCRs and GPCR-related proteins, i.e., receptors (GPCRs), the largest family of membrane receptors those upstream of or downstream from GPCRs, represent molpharm.aspetjournals.org that are targeted by approved drugs, and the number of such ∼17% of all protein targets for approved drugs, with GPCRs drugs that target GPCRs. We review current knowledge themselves accounting for ∼12%. As such, GPCRs consti- regarding GPCRs as drug targets by integrating data from tute the largest family of proteins targeted by approved public databases (ChEMBL, Guide to PHARMACOLOGY, and drugs. Drugs that currently target GPCRs and GPCR- DrugBank) and from the Broad Institute Drug Repurposing related proteins are primarily small molecules and peptides. Hub. To account for discrepancies among these sources, we Since ∼100 of the ∼360 human endo-GPCRs (other than curated a list of GPCRs currently targeted by approved drugs.
    [Show full text]